SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cerner Corp – ‘10-Q’ for 9/30/17 – ‘R23’

On:  Friday, 10/27/17, at 4:02pm ET   ·   For:  9/30/17   ·   Accession #:  804753-17-39   ·   File #:  0-15386

Previous ‘10-Q’:  ‘10-Q’ on 7/28/17 for 7/1/17   ·   Next:  ‘10-Q’ on 5/3/18 for 3/31/18   ·   Latest:  ‘10-Q’ on 5/3/22 for 3/31/22   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/27/17  Cerner Corp                       10-Q        9/30/17   60:6M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    535K 
 2: EX-10.1     Material Contract                                   HTML     80K 
 8: EX-10.10    Material Contract                                   HTML    148K 
 3: EX-10.2     Material Contract                                   HTML     30K 
 4: EX-10.3     Material Contract                                   HTML     35K 
 5: EX-10.4     Material Contract                                   HTML     36K 
 6: EX-10.5     Material Contract                                   HTML     43K 
 7: EX-10.6     Material Contract                                   HTML     35K 
 9: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
10: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
11: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
12: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
19: R1          Document And Entity Information                     HTML     36K 
20: R2          Consolidated Balance Sheets                         HTML    105K 
21: R3          Consolidated Balance Sheets (Parenthetical)         HTML     25K 
22: R4          Consolidated Statements Of Operations               HTML     74K 
23: R5          Consolidated Statements Of Operations               HTML     20K 
                (Parenthetical)                                                  
24: R6          Consolidated Statements Of Comprehensive Income     HTML     31K 
25: R7          Consolidated Statements Of Comprehensive Income     HTML     22K 
                (Parenthetical)                                                  
26: R8          Consolidated Statements Of Cash Flows               HTML    101K 
27: R9          Interim Statement Presentation (Notes)              HTML     64K 
28: R10         Fair Value Measurements                             HTML     79K 
29: R11         Investments                                         HTML    120K 
30: R12         Receivables                                         HTML     39K 
31: R13         Income Taxes                                        HTML     21K 
32: R14         Earnings Per Share                                  HTML     87K 
33: R15         Share-Based Compensation                            HTML     88K 
34: R16         Contingencies                                       HTML     24K 
35: R17         Segment Reporting                                   HTML    124K 
36: R18         Fair Value Measurements (Tables)                    HTML     73K 
37: R19         Investments Investments (Tables)                    HTML    117K 
38: R20         Receivables (Tables)                                HTML     32K 
39: R21         Earnings Per Share (Tables)                         HTML     84K 
40: R22         Share-Based Compensation (Tables)                   HTML     91K 
41: R23         Segment Reporting (Tables)                          HTML    123K 
42: R24         Interim Statement Presentation Policies (Details)   HTML    111K 
43: R25         Fair Value Measurements (Narrative) (Details)       HTML     22K 
44: R26         Fair Value Measurements Fair Value, Assets and      HTML     43K 
                Liabilities Measured at Fair Value on a Recurring                
                Basis (Details)                                                  
45: R27         Investments (Narrative) (Details)                   HTML     19K 
46: R28         Investments (Details)                               HTML     52K 
47: R29         Receivables (Narrative) (Details)                   HTML     19K 
48: R30         Receivables (Summary Of Net Receivables) (Details)  HTML     31K 
49: R31         Income Taxes (Details)                              HTML     20K 
50: R32         Earnings Per Share (Reconciliation Of The           HTML     39K 
                Numerators And The Denominators Of The Basic And                 
                Diluted Per Share) (Details)                                     
51: R33         Earnings Per Share (Narrative) (Details)            HTML     25K 
52: R34         Share-Based Compensation (Schedule Of Stock         HTML     53K 
                Options Activity) (Details)                                      
53: R35         Share-Based Compensation (Schedule of Share-based   HTML     27K 
                Payment Award, Stock Options, Valuation                          
                Assumptions) (Details)                                           
54: R36         Share-Based Compensation (Schedule Of Non-Vested    HTML     40K 
                Shares Activity) (Details)                                       
55: R37         Share-Based Compensation (Compensation Expense      HTML     31K 
                Recognized In The Condensed Consolidated                         
                Statements Of Operations) (Details)                              
56: R38         Share-Based Compensation (Narrative) (Details)      HTML     38K 
57: R39         Segment Reporting (Summary Of The Operating         HTML     39K 
                Information) (Details)                                           
59: XML         IDEA XML File -- Filing Summary                      XML     90K 
58: EXCEL       IDEA Workbook of Financial Reports                  XLSX     51K 
13: EX-101.INS  XBRL Instance -- cern-20170930                       XML   1.54M 
15: EX-101.CAL  XBRL Calculations -- cern-20170930_cal               XML    149K 
16: EX-101.DEF  XBRL Definitions -- cern-20170930_def                XML    369K 
17: EX-101.LAB  XBRL Labels -- cern-20170930_lab                     XML    855K 
18: EX-101.PRE  XBRL Presentations -- cern-20170930_pre              XML    490K 
14: EX-101.SCH  XBRL Schema -- cern-20170930                         XSD     87K 
60: ZIP         XBRL Zipped Folder -- 0000804753-17-000039-xbrl      Zip    135K 


‘R23’   —   Segment Reporting (Tables)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.8.0.1
Segment Reporting (Tables)
9 Months Ended
Segment Reporting [Abstract]  
Summary of the Operating Information
The following table presents a summary of our operating segments and other expense for the three and nine months ended September 30, 2017 and October 1, 2016:
(In thousands)
Domestic
 
Global    
 
Other    
 
Total    
 
 
 
 
 
 
 
 
Three Months Ended 2017
 
 
 
 
 
 
 
Revenues
$
1,133,971

 
$
142,036

 
$

 
$
1,276,007

 
 
 
 
 
 
 
 
Cost of revenues
176,198

 
26,706

 

 
202,904

Operating expenses
502,256

 
68,229

 
254,712

 
825,197

Total costs and expenses
678,454

 
94,935


254,712

 
1,028,101

 
 
 
 
 
 
 
 
Operating earnings (loss)
$
455,517

 
$
47,101

 
$
(254,712
)
 
$
247,906


(In thousands)
Domestic
 
Global    
 
Other    
 
Total    
 
 
 
 
 
 
 
 
Three Months Ended 2016
 
 
 
 
 
 
 
Revenues
$
1,055,037

 
$
129,520

 
$

 
$
1,184,557

 
 
 
 
 
 
 
 
Cost of revenues
161,625

 
21,345

 

 
182,970

Operating expenses
446,704

 
60,430

 
252,228

 
759,362

Total costs and expenses
608,329

 
81,775

 
252,228

 
942,332

 
 
 
 
 
 
 
 
Operating earnings (loss)
$
446,708

 
$
47,745

 
$
(252,228
)
 
$
242,225


(In thousands)
Domestic
 
Global    
 
Other    
 
Total    
 
 
 
 
 
 
 
 
Nine Months Ended 2017
 
 
 
 
 
 
 
Revenues
$
3,421,429

 
$
407,058

 
$

 
$
3,828,487

 
 
 
 
 
 
 
 
Cost of revenues
549,895

 
75,065

 

 
624,960

Operating expenses
1,474,591

 
197,333

 
790,183

 
2,462,107

Total costs and expenses
2,024,486

 
272,398

 
790,183

 
3,087,067

 
 
 
 
 
 
 
 
Operating earnings (loss)
$
1,396,943

 
$
134,660

 
$
(790,183
)
 
$
741,420

(In thousands)
Domestic
 
Global    
 
Other    
 
Total    
 
 
 
 
 
 
 
 
Nine Months Ended 2016
 
 
 
 
 
 
 
Revenues
$
3,132,566

 
$
406,088

 
$

 
$
3,538,654

 
 
 
 
 
 
 
 
Cost of revenues
488,404

 
75,715

 

 
564,119

Operating expenses
1,304,731

 
183,824

 
786,995

 
2,275,550

Total costs and expenses
1,793,135

 
259,539

 
786,995

 
2,839,669

 
 
 
 
 
 
 
 
Operating earnings (loss)
$
1,339,431

 
$
146,549

 
$
(786,995
)
 
$
698,985


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/27/17
For Period end:9/30/17
10/1/1610-Q
 List all Filings 


2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/22  Cerner Corp.                      10-K       12/31/21  135:13M
 2/19/21  Cerner Corp.                      10-K       12/31/20  140:13M
Top
Filing Submission 0000804753-17-000039   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 1:28:28.1pm ET